A non-hallucinogenic psychedelic analogue with therapeutic potentialLindsay P. Cameron, David E. Olson, Taohui Liu et al.|Nature|2020Cited by 461
An artificial intelligence accelerated virtual screening platform for drug discoveryGuangfeng Zhou, Frank DiMaio, Domnița-Valeria Rusnac et al.|Nature Communications|2024Cited by 189
Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microgliaHai M. Nguyen, Heike Wulff|Glia|2016Cited by 171
Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic strokeYi‐Je Chen, Heike Wulff|Annals of Clinical and Translational Neurology|2017Cited by 72
KCa3.1 Channel Modulators as Potential Therapeutic Compounds for GlioblastomaBrandon M. Brown, Heike Wulff|Current Neuropharmacology|2017Cited by 48